matrix metalloproteinase-11

(redirected from Stromelysin-3)
Also found in: Acronyms.

matrix metalloproteinase-11

A matrix metalloproteinase encoded on chromosome 22q11.2 which degrades extracellular matrix, collagens and other tissue substrates.

Cytokine inducers
EGF, FGF-b, IGF-II, IL-6, PDGF, TGF-alpha.
 
Substrates
Alpha1-antitrypsin, alpha2-macroglobulin, casein, IGF-binding protein-1.

Normal expression
Increased expression and activation during wound healing; migration and extracellular matrix remodeling is accompanied by acquisition of a mesenchymal phenotype in respiratory epithelial cells.

Abnormal expression
MMP-11 appears in the desmoplastic stroma of invasive, but not in situ, breast carcinoma; its transcription may be induced by diffusible cytokines (e.g., PDGF, fibroblast growth factor, TGF-alpha), providing a mechanism by which malignant cells destroy basement membranes and invade tissues.
Mentioned in ?
References in periodicals archive ?
Collagenases, gelatinases, stromelysin-3, matrilysin, MT1-MMP [99], and stromelysin-1 [100] are considered the most closely associated to the invasive phenotype.
High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma.
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.
Expression of stromelysin-3 in atherosclerotic lesion: regulation via CD40-CD40 ligand signaling in vitro and in vivo.